Scarica l'app Stockscreener
2.03
0.98%
-0.02
Dopo l'orario di chiusura:
2.00
-0.03
-1.48%
Precedente Chiudi:
$2.05
Aprire:
$2.1
Volume 24 ore:
247.53K
Relative Volume:
0.87
Capitalizzazione di mercato:
$46.25M
Reddito:
-
Utile/perdita netta:
$-13.76M
Rapporto P/E:
-2.1828
EPS:
-0.93
Flusso di cassa netto:
-
1 W Prestazione:
+3.05%
1M Prestazione:
-12.12%
6M Prestazione:
+84.55%
1 anno Prestazione:
+144.87%
Intervallo 1D:
$1.945
$2.10
Intervallo di 1 settimana:
$1.825
$2.10
Portata 52W:
$0.5985
$2.60
Neurosense Therapeutics Ltd Stock (NRSN) Company Profile
Nome
Neurosense Therapeutics Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta NRSN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NRSN
Neurosense Therapeutics Ltd
|
2.03 | 46.25M | 0 | -13.76M | 0 | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Neurosense Therapeutics Ltd Borsa (NRSN) Ultime notizie
What analysts say about NeuroSense Therapeutics Ltd. stock outlookUnmatched profit growth - jammulinksnews.com
What analysts say about NeuroSense Therapeutics Ltd. stockExceptional stock performance - PrintWeekIndia
How NeuroSense Therapeutics Ltd. Equity Warrant stock reacts to Fed policy changesExtraordinary earning power - jammulinksnews.com
Will NeuroSense Therapeutics Ltd. Equity Warrant stock benefit from AI tech trendsExtraordinary profit generation - jammulinksnews.com
Can NeuroSense Therapeutics Ltd. stock recover from recent declineOutstanding risk-reward balance - jammulinksnews.com
What analysts say about NeuroSense Therapeutics Ltd. Equity Warrant stockExplosive market performance - Autocar Professional
Is NeuroSense Therapeutics Ltd. a good long term investmentExponential return rates - Autocar Professional
What drives NeuroSense Therapeutics Ltd. Equity Warrant stock priceOutstanding stock performance - Autocar Professional
NeuroSense Therapeutics Ltd. Equity Warrant Stock Analysis and ForecastFree Bull & Bear Market Updates - jammulinksnews.com
NeuroSense Therapeutics Ltd. Stock Analysis and ForecastMassive wealth growth - jammulinksnews.com
What drives NeuroSense Therapeutics Ltd. stock priceSuperior trading gains - jammulinksnews.com
Is NeuroSense Therapeutics Ltd. Equity Warrant a good long term investmentBreakthrough wealth creation - jammulinksnews.com
Award-Winning Broadway, Television & Film Star Aaron Lazar Featuring NeuroSense CEO Alon Ben-Noon in a Special Live Podcast on ALS Science, PrimeC's Commercialization Strategies, and Community - PR Newswire
Why NeuroSense Therapeutics Ltd. Equity Warrant stock attracts strong analyst attentionStable Stocks With High Yield - Newser
How NeuroSense Therapeutics Ltd. Equity Warrant stock performs during market volatilityROI Driven Alerts - Newser
how neurosense therapeutics ltd. stock performs during market volatilityFree Access to Stock Community - Newser
What makes NeuroSense Therapeutics Ltd. Equity Warrant stock price move sharplyTrade Ready Signal - Newser
How NeuroSense Therapeutics Ltd. stock performs during market volatilityFree Long-Term Wealth Growth Plan - Newser
What makes NeuroSense Therapeutics Ltd. stock price move sharplyMassive Profit Potential - Newser
Neurosense Therapeutics Ltd Azioni (NRSN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):